Brennan John Owen has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 77633 shares of ImmunityBio, Inc. ($IBRX) on June 11, 2024.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2024 | ImmunityBio, Inc. | $IBRX | Brennan John Owen | Director | A | Stock Option (right to buy) | 77633 | $0.00 | 77,633.0000 | 677,003,411 | 9999.99% | 0.01% |
| June 13, 2023 | ImmunityBio, Inc. | $IBRX | Brennan John Owen | Director | A | Stock Option (right to buy) | 158263 | $0.00 | 158,263.0000 | 421,569,115 | 9999.99% | 0.04% |
| June 2, 2023 | ImmunityBio, Inc. | $IBRX | Brennan John Owen | Director | P | Common Stock | 5000 | $2.74 | 5,000.0000 | 421,569,115 | 9999.99% | 0.00% |
| June 2, 2023 | ImmunityBio, Inc. | $IBRX | Brennan John Owen | Director | P | Common Stock | 10000 | $2.80 | 15,000.0000 | 421,569,115 | 200.00% | 0.00% |
| June 2, 2023 | ImmunityBio, Inc. | $IBRX | Brennan John Owen | Director | P | Common Stock | 10000 | $2.90 | 25,000.0000 | 421,569,115 | 66.67% | 0.00% |